Preeclampsia Diagnostics Market to reach USD 1.59 Billion By 2032 with a growing CAGR of 2.98%
The Preeclampsia Diagnostics Market is experiencing robust growth, driven by advancements in diagnostic technologies and increasing awareness of maternal health risks. Preeclampsia, a hypertensive disorder affecting 2%–8% of pregnancies globally, remains a leading cause of maternal and neonatal mortality. The condition’s rising prevalence, attributed to factors such as obesity, advanced maternal age, and pre-existing health conditions like hypertension and diabetes, underscores the urgent need for early and accurate diagnostic solutions.